In hyperglycemic model, after 2 week-treatment, glucose levels of mice treated with Mimostam capsule at 0.5 g / kg and 1 g / kg were decreased 41.4% and 37.2% respectively, compared to 63.1% of 5 mg / kg glibenclamide group.